Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | -6.12% | -3.36% | +18.56% |
Mar. 04 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 28 | Lyell Immunopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 2M | Sales 2025 * | 2.5M | Capitalization | 586M |
---|---|---|---|---|---|
Net income 2024 * | -225M | Net income 2025 * | -259M | EV / Sales 2024 * | 28.5 x |
Net cash position 2024 * | 529M | Net cash position 2025 * | 623M | EV / Sales 2025 * | -14.5 x |
P/E ratio 2024 * |
-2.64
x | P/E ratio 2025 * |
-2.51
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.13% |
1 day | -6.12% | ||
1 week | -3.36% | ||
Current month | +3.14% | ||
1 month | +19.79% | ||
3 months | +10.58% | ||
6 months | +41.98% | ||
Current year | +18.56% |
Managers | Title | Age | Since |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 21-04-30 |
Charles Newton
DFI | Director of Finance/CFO | 53 | 21-01-31 |
Stephen Hill
COO | Chief Operating Officer | 53 | 19-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 21-04-30 |
Robert Nelsen
BRD | Director/Board Member | 60 | 18-08-31 |
Otis Brawley
BRD | Director/Board Member | 64 | 21-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.01% | 237 M€ | +1.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.3 | -5.74% | 775,286 |
24-04-23 | 2.44 | +1.24% | 687,131 |
24-04-22 | 2.41 | +8.07% | 958,851 |
24-04-19 | 2.23 | -4.29% | 1,080,193 |
24-04-18 | 2.33 | -2.10% | 906,620 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.56% | 586M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.46% | 22.2B | |
-16.53% | 21.23B | |
-9.00% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- LYEL Stock